Final Notice
FINAL NOTICE 
Individual ref:  
CTR00006 
TAKE NOTICE: The Financial Services Authority of 25 The North Colonnade, Canary 
Wharf, London E14 5HS (“the FSA”) gives you, Mr Ceri Rees, final notice about the 
imposition of a financial penalty, the withdrawal of your individual approval and the 
making of two prohibition orders:  
1. 
ACTION 
1.1. 
On 25 November 2010 the FSA gave you a Decision Notice which stated that it had 
decided:  
(1) 
pursuant to section 66 of the Financial Services and Markets Act 2000 (“the 
Act”), to impose on you a financial penalty of £17,500 for failing to comply 
with Statements of Principle 2 and 7 of the FSA’s Statements of Principle and 
Code of Practice for Approved Persons (“Statements of Principle”); 
(2) 
pursuant to section 63 of the Act, to withdraw the approval given to you to 
perform the significant influence functions of CF4 Partner, CF10 Compliance 
Oversight and CF11 Money Laundering at Clark Rees LLP (the “LLP”) 
because you lack the competence and capability to perform these functions;  
(3) 
pursuant to section 56 of the Act, to make an order prohibiting you from 
performing any significant influence function in relation to any regulated 
activity carried on by any authorised person, exempt person or exempt 
professional firm (the “Prohibition Order”); and 
(4) 
to make a further order, pursuant to section 56 of the Act, prohibiting you for a 
period of two years from the date of this notice from performing all customer 
functions (CF30) in relation to sales of unregulated collective investments 
schemes (“UCIS”) (the “Time Limited Prohibition Order”). 
1.2. 
You agreed to settle this matter at an early stage of the FSA’s investigation and you 
therefore qualified for a 30 per cent (Stage 1) discount under the FSA’s executive 
settlement procedures.  Without this discount, the FSA would have sought to impose a 
financial penalty of £25,000 on you.   
2. 
REASONS FOR THE ACTION 
2.1. 
Between 15 November 2007 and 22 October 2009 (“the relevant period”), you were 
approved by the FSA to perform the controlled functions of CF4 (Partner), CF10 
(Compliance Oversight), CF11 (Money Laundering Reporting) and CF30 (Customer) 
at the LLP. You were also approved to perform the controlled function of CF8 
(Apportionment and Oversight) between 15 November 2007 and 31 March 2009.  
2.2. 
For the reasons set out more fully in section 4 below:  
(1) 
you failed to act with due skill, care and diligence in carrying out your 
controlled functions (in contravention of Statement of Principle 2) by: 
(a) 
failing to inform yourself about and demonstrate an understanding of 
the regulatory requirements relating to the promotion of UCIS and, in 
particular, you were not aware of the statutory restriction on the 
promotion of UCIS in section 238 of the Act (“the section 238 
restriction”) and the exemptions to that restriction; and 
(b) 
failing to inform yourself about and apply correctly the rules relating to 
regulatory capital requirements; and 
(2) 
you failed to take reasonable steps to ensure that the business of the LLP for 
which you were responsible in your controlled functions complied with the 
relevant requirements and standards of the regulatory system (in contravention 
of Statement of Principle 7) by failing to: 
a) ensure that the LLP had regard to the section 238 restriction and any 
relevant exemptions to it before promoting UCIS to its customers;  
b) take 
reasonable 
steps 
to 
ensure 
that 
the 
LLP’s 
personal 
recommendations to its customers to invest in UCIS were suitable 
(including a failure to meet the information gathering requirements in 
section 9 of the FSA’s Conduct of Business Sourcebook (“COBS”)); 
c) demonstrate an understanding of the Treating Customers Fairly 
principles; 
d)  ensure that, when handling complaints, the LLP was organised so that 
it could identify and remedy any recurring or systemic problems; 
e) ensure that the LLP adequately disclosed and managed a potential 
conflict of interest arising from the involvement of both partners in a 
UCIS into which customers of the LLP were advised to invest;  
f) ensure that the LLP’s advisers were properly supervised and had the 
competence, knowledge, and skills to give investment advice;  
g) ensure that the LLP had adequate financial resources and met its 
regulatory capital requirements since it became authorised by the FSA; 
h) ensure that the LLP submitted its Retail Mediation Activities Return to 
the FSA in a timely and accurate manner; and 
i) ensure that the LLP dealt with the FSA in an open and co-operative 
way, by disclosing matters relating to it of which the FSA would 
reasonably expect notice. 
2.3. 
The FSA concluded that your conduct was particularly serious because your failures 
exposed customers to a risk of receiving unsuitable recommendations in relation to 
retail investment products. 
2.4. 
Due to your failure to take reasonable steps to ensure that the LLP retained 
appropriate records to demonstrate whether its advisers assessed and, if so, the basis 
on which its advisers assessed the suitability of the products they recommended, the 
FSA was unable to satisfy itself that customers were recommended suitable 
investment products.  
2.5. 
The FSA concluded that your conduct during the relevant period demonstrated that 
you had failed to comply with Statements of Principle 2 and 7, for which a financial 
penalty is appropriate.  The FSA also concluded that you lack the competence and 
capability to perform significant influence controlled functions at the LLP, and 
therefore you were not a fit and proper person to perform any significant influence 
functions in relation to regulated activities carried on by authorised persons, exempt 
persons and exempt professional firms. It was therefore also necessary and 
proportionate to withdraw your individual approval and to make a prohibition order 
and a further time limited prohibition order, in support of the FSA’s consumer 
protection and market confidence objectives.   
3. 
RELEVANT STATUTORY AND REGULATORY PROVISIONS 
3.1. 
The relevant statutory provisions and regulatory requirements are set out at Annex A. 
4. 
FACTS AND MATTERS RELIED ON 
4.1. 
The LLP was a small investment partnership based in Cardiff.  With effect from 15 
November 2007, the LLP was authorised by the FSA to carry on the following 
regulated activities: 
(1) 
advising on investments (excluding pension transfers/opt outs); 
(2) 
agreeing to carry on a regulated activity; 
(3) 
arranging deals in investments; and 
(4) 
making arrangements. 
4.2. 
The LLP was set up as a limited liability partnership and run by you and Mr Paul 
Clark.  On 7 May 2009 Mr Clark withdrew his approved person status. On 22 October 
2009, you voluntarily varied the LLP’s permission by adding a requirement that it 
would not undertake any regulated activity. The LLP conducted a low volume of 
regulated business, completing 50 retail investment sales between 15 November 2007 
and 15 July 2010.  It had approximately 70 customers of whom 11 invested in one or 
more of three UCIS.  
4.3. 
During the relevant period, you and Mr Clark were the partners and the approved 
persons performing significant influence functions at the LLP. During the relevant 
period, there were between two and four investment advisers at the LLP, including 
you and Mr Clark. You were both responsible for the day-to-day running of LLP and 
for the decision making.   Accordingly, you were jointly responsible for taking 
reasonable steps to ensure that the business of the LLP was organised so that it 
complied with regulatory requirements and the standards of the regulatory system.   
4.4. 
On 8 October 2009, the FSA visited Clark Rees LLP. During the visit, the FSA 
reviewed a sample of 16 electronic client files and noted the absence of key 
information on the client files relevant to demonstrating the suitability of personal 
recommendations made by the LLP’s advisers.  The FSA also identified a number of 
serious concerns about the promotion of and personal recommendations to invest in 
UCIS, and the management and disclosure of a conflict of interest, and the adequacy 
of the LLP’s capital resources.  
4.5. 
For the reasons set out below, the FSA concluded that the LLP fell below the 
standards expected of authorised firms. 
Promotion of UCIS 
4.6. 
The section 238 restriction prohibits authorised persons from communicating an 
invitation or inducement to participate in a collective investment scheme. There are a 
number of exemptions to the section 238 restriction which an authorised firm could 
rely on to promote UCIS to its retail customers.  
4.7. 
By not paying due regard to the statutory and regulatory restrictions on the promotion 
of UCIS before recommending its customers to invest in UCIS, the LLP may have 
acted unlawfully and potentially exposed its customers to the risk of receiving 
unsuitable investment advice. It failed to comply with Principle 9 of the FSA’s 
Principles for Businesses (“the Principles”) which requires it to take reasonable care 
to ensure the suitability of its advice for any customer who is entitled to rely upon its 
judgment.  As senior management at the firm, you were responsible for these failings. 
4.8. 
The relevant regulatory provisions relating to UCIS are summarised in Annex B to 
this Notice. 
4.9. 
The FSA identified 11 customers who were advised by the LLP to invest in one or 
more of three UCIS.  One of the UCIS (“the Scheme”) was a scheme that was set up 
by you and Mr Clark. The FSA found no evidence that the LLP had correctly applied 
the relevant exemptions before promoting UCIS to customers, thereby contravening 
the section 238 restriction.  
4.10. On 18 March 2010, you admitted that you were unaware of the statutory and 
regulatory restrictions relating to UCIS and you failed to demonstrate an adequate 
understanding of the specific requirements regarding client certification (such as the 
requirements for certifying customers as high net worth individuals). You told the 
FSA that all letters issued to UCIS customers until May 2009 incorrectly described 
them as “sophisticated and experienced investors” instead of referring to the 
exemption categories in the Financial Services and Markets Act 2000 (Promotion of 
collective investment schemes) (Exemptions) Order 2001 (“the PCIS Order”) and/or 
the categories in COBS 4.12. The FSA found no evidence that customers of the LLP 
had been categorised in accordance with the PCIS Order or COBS 4.12 before they 
received UCIS promotions from the LLP. 
4.11. You also failed to ensure that the LLP made personal recommendations to its 
customers to invest in UCIS without first adequately assessing and documenting the 
customers’ personal and financial circumstances and knowledge and experience of 
this type of investment. 
4.12. You failed to take reasonable steps to ensure that the LLP made suitable 
recommendations to its customers, placing the LLP in contravention of COBS 9.2.1R. 
The FSA found no satisfactory evidence that the LLP’s advisers had complied with 
the requirements in COBS 9 as there was an absence of key information on client files 
such as fact finds, product research and suitability letters. You said that, upon 
migrating data to a new electronic record keeping system, a number of key documents 
had gone missing. You provided the investigation team with missing documentation 
in March 2010. The FSA reviewed the additional documentation and identified the 
following deficiencies in the fully assembled client records:  
(1) 
there were missing documents and inadequate information on client files to 
demonstrate the adviser’s awareness and understanding of the customer’s 
financial circumstances, investment objectives and knowledge and experience 
of financial products (and you accepted that manuscript notes had been 
destroyed and that certain information such as customers’ objectives, assets, 
liabilities and attitude to risk were missing from fact finds which you 
attributed to data loss); 
(2) 
there was insufficient evidence of product research, consideration of 
alternative products and/or independent due diligence on files, and no 
evidence of research to compare the recommended product with the 
customer’s existing investment in cases where transfers/switches had been 
recommended; 
(3) 
in some cases, the advice was inconsistent with the customers’ stated needs 
and preferences and you accepted that it was not clear in one file how the 
recommended UCIS met the customer’s objectives; 
(4) 
assessments of customers’ attitude to risk were missing or inadequate, and 
there was insufficient evidence to show that customers understood the risks 
involved in recommended transactions;   
(5) 
there were no documented assessments of the risk of exposing significant 
proportions of customers’ assets to UCIS investments;  
(6) 
there was no evidence of a policy on the diversification of customer portfolios 
to mitigate the risks associated with investments in UCIS and manage 
concentration risk;  
(7) 
one customer who was near to retirement invested 60% of his portfolio in 
UCIS and another retired customer invested 55% of his (tax-free) retirement 
lump sum in UCIS and, in both cases, there was no evidence to show that they 
could tolerate a partial or the complete loss of capital invested; and 
(8) 
there was insufficient evidence on files to demonstrate suitability and UCIS 
customers were issued with letters wrongly classifying them as “sophisticated 
and experienced investors”, with insufficient explanations as to how the 
recommended product was suitable for them. 
4.13. As a result of the failings in the LLP’s sales process identified above, at least 11 
customers were exposed to the risks of receiving unsuitable advice and put in a 
position in which they made investment decisions based on incomplete and/or 
misleading information. 
Capital adequacy and reporting failures  
4.14. The LLP’s Retail Mediation Activity Return (“RMAR”) for the period ended 31 
March 2008 showed that it had wrongly relied on the partners’ personal assets to meet 
the capital requirements. You said that you had included the partners’ personal assets 
in support of the evidence in the LLP’s FSA authorisation application that it was 
satisfying Threshold Condition 4 (Adequate resources). You said that it was only after 
you received a letter from the FSA questioning the inclusion of these assets that you 
became aware that personal assets could not be included for a limited liability 
partnership. You said that the LLP had been advised incorrectly by e-mail on this 
matter by an external compliance consultant, but you were unable to find the e-mail.  
4.15. To rectify the deficit, you provided a member’s capital agreement that showed initial 
capital of £13,779. You also provided accounts that showed a balance on the partners’ 
account of £16,801 as at 28 February 2007. However, the LLP’s financial statements 
for the year ended 31 March 2007 showed a balance on the partners’ account of 
£(191,438). The LLP failed to comply with a document request dated 2 June 2010 
relating to this discrepancy. 
4.16. As at September 2009, the LLP had failed to submit RMARs for the periods ending 
30 September 2008 and 31 March 2009. You stated that this was an oversight and that 
the reminders had failed to appear in your diary because of the LLP’s IT problems.   
4.17. When the LLP submitted the late RMARs to the FSA on 28 September 2009, it was 
evident that both returns had incorrectly double-counted the net profits (i.e. the net 
profits were included as a separate item in the capital resources calculation when they 
had already been included as part of the balance on the partners’ accounts). You 
failed to explain to the FSA’s satisfaction why this had occurred and you said that you 
would speak to the LLP’s accountant about it. On 20 April 2010, the FSA sent an 
7 
 
information request regarding this issue.  You failed to ensure that the LLP complied 
with the request.  
4.18. A review of the information underpinning the March 2009 RMAR identified the 
inclusion of a debt owed to the LLP by a connected company, Company A. You and 
Mr Clark were also directors of Company A and as such you knew they had no 
realistic prospect of recovering the debt because that company had gone into 
administration. When the LLP revised its accounts and removed the debt, it was 
evident that it did not have sufficient capital.  You told the FSA that you reviewed the 
RMARs prior to their submission but that you relied on the LLP’s accountant to 
understand what was required.    
4.19. The LLP’s complaints returns for the reporting period April to September 2008 and 
October 2008 to March 2009 were incorrectly completed and inconsistent with the 
LLP’s own complaints register.  
4.20. You therefore failed to act with due skill, care and diligence by failing to inform 
yourself about the FSA’s capital requirements and to take reasonable steps to ensure 
that the LLP met its capital requirements. You failed to ensure that the LLP submitted 
accurate and complete reports to the FSA by the due date, in breach of paragraph 
16.12 of the FSA’s Supervision manual (“SUP”) and complied with all statutory 
information and document requests. 
Potential conflict of interest 
4.21. The Scheme was an offshore UCIS set up by you and Mr Clark in 2008. You were 
also the two directors of the investment manager for the Scheme.  In December 2009 
you resigned from the investment manager as a director and shareholder. As the 
founder shareholders of the Scheme, you had the right to appoint and replace the 
directors.  The Scheme’s Private Placement Memorandum (“PPM”) dated 28 July 
2008 stated that the Scheme would pay the investment manager fees for its services. 
During the relevant period, the Scheme invested in a particular partnership on the 
investment manager’s recommendation.  
4.22. While the partners were directors of the investment manager, which was responsible 
for the Scheme’s investment management operations, the LLP promoted the Scheme 
to some of its customers and purported to provide them with independent advice in 
relation to it. Since December 2008, eight customers invested in the Scheme. 
4.23. Although the PPM recorded the Scheme’s approach to potential conflicts of interest, 
the FSA considers that it did not adequately disclose the potential conflict of interest 
between the partners’ investment management role for the Scheme and their role as 
independent financial advisers at the LLP. You confirmed that the PPM was the only 
document in which the potential conflict was disclosed and considered that this 
disclosure was absolutely clear and sufficient to avoid a conflict. You stated that the 
investment manager had never received any payment from the Scheme, and that you 
considered that sufficient steps had been taken to manage the potential conflict.  
4.24. In May 2009 you took another view of the potential conflict, which resulted in Mr 
Clark’s resignation as an IFA from the LLP which he did on 7 May 2009. You 
stopped discussing the Scheme fund with the LLP’s customers in June 2009, resigned 
from the investment manager as a director and shareholder and made arrangements 
for a new investment manager to replace the existing one.  You remain an investor of 
the Scheme.  
4.25. The FSA considered that between July 2008 and June 2009 your role as director of 
the investment manager represented a conflict of interest in respect of the independent 
of advice given by the LLP to its customers and the financial incentives to increase 
the funds under management by the investment manager. In addition, the LLP failed 
to manage this conflict and disclose it adequately to its customers before making 
personal recommendations to them to invest in the Scheme.  
4.26. Given the significant influence functions performed by you, the FSA concluded that 
you were responsible for the LLP’s failure to adequately recognise, disclose and 
manage this conflict of interest.   
Misleading customer communications 
4.27. The LLP issued letters to all customers who invested in UCIS which described them 
as “sophisticated and experienced”, although the LLP purported to rely on the COBS 
4.12 exemption categories. The letters stated that a customer should only invest in 
such holdings if they regarded themselves as a sophisticated and experienced investor. 
The LLP regarded these long-standing customers as sophisticated and experienced 
investors due to their attitude to risk and because they had built up money in pension 
funds and had other investments. In the letter, the LLP went on to state there was no 
clear definition of a sophisticated and experienced investor, and that the LLP 
considered that that a key component to this was that the customer must regard 
himself or herself as a sophisticated and experienced investor.  
4.28. The FSA considered the letter to be misleading because: 
(1) 
it gave customers the impression that they had been categorised as 
sophisticated and experienced when in practice no compliant assessments 
against these exemptions had been undertaken; 
(2) 
“sophisticated and experienced” is not a category of exemption under the 
PCIS Order or COBS 4.12;  
(3) 
there are two types of sophisticated investors referred to in the PCIS Order – 
certified and self-certified - and there are specific definitions and requirements 
for each type. However, you state in some of your suitability letters that you 
consider the customers as sophisticated investors because they hold pensions 
and investments; and 
(4) 
the letters were confusing because they inferred that customers should assess 
their own eligibility for UCIS, yet they stated that the LLP also assessed them. 
Therefore it was difficult to determine whether the customer had been dealt 
with as a self-certified sophisticated investor or certified by a firm as a 
sophisticated investor.  
4.29. You accepted that the letter to customers did not accurately reflect the prescribed 
requirements for a sophisticated investor.  
4.30. The FSA concluded that you failed to ensure that the LLP communicated with 
customers in way that was clear, fair and not misleading, in breach of Statement of 
Principle 7.  
Compliance management oversight 
4.31. You were responsible for the compliance function at the LLP.  The LLP did not 
engage an external compliance firm after it became authorised.   
File checking 
4.32. You failed to take reasonable steps to ensure that personal recommendations to 11 
customers to invest in UCIS were properly monitored and the advisers adequately 
supervised. File reviews and discussions with advisers were not documented so you 
could provide no evidence that such reviews took place or that they were effective. 
You accepted that some fact find documents were incomplete and that some 
correspondence with customers was unclear. Mr Clark described file reviews and 
compliance checks as “ad hoc”. You accepted that while some of your work was 
overseen by an adviser, other files were not reviewed at all. 
4.33. The FSA concluded that, in practice, there was no formal process to ensure that files 
were adequately reviewed or a formal process to disseminate lessons learned in 
respect of each adviser and in respect of systemic issues.  
4.34. The LLP’s approach to complaint handling was inadequate. As the LLP’s complaints 
officer, you failed to ensure that all complaints were recorded as complaints. You 
showed a lack of understanding of complaint handling rules in that you stated that 
administrative matters were not considered to be complaints and that customers were 
asked to put complaints about advice in writing before they could be considered.  
4.35. The FSA concluded that you failed to establish adequate compliance monitoring 
procedures to ensure that the LLP complied with the relevant requirements of the 
regulatory system. 
Management information 
4.36. The LLP also failed to adequately monitor business written.  Consequently you failed 
to identify that the LLP’s recommendations resulted in a high concentration of some 
customers’ overall savings and investment portfolio in UCIS. 
5. 
ANALYSIS OF THE SANCTIONS 
Imposition of financial penalty 
5.1. 
The FSA's policy on the imposition of financial penalties relevant to the misconduct 
as detailed in this Notice is set out in Chapter 6 of the version of the Decision 
Procedure and Penalties Manual (“DEPP”) in force prior to 6 March 2010, which 
formed part of the FSA Handbook. All references to DEPP in this section are 
references to that version of DEPP.   
5.2. 
The principal purpose of imposing a financial penalty is to promote high standards of 
regulatory conduct by deterring persons who have committed breaches from 
committing further breaches, helping to deter other persons from committing similar 
breaches and demonstrating generally the benefits of compliant behaviour. 
5.3. 
In determining whether a financial penalty is appropriate the FSA is required to 
consider all the relevant circumstances of a case. 
5.4. 
DEPP 6.5.2G sets out a non-exhaustive list of factors that may be of relevance in 
determining the level of a financial penalty. The FSA considered that the following 
factors are particularly relevant in this case. 
Deterrence (DEPP 6.5.2(1)) 
5.5. 
In determining the level of the financial penalty, the FSA had regard to the need to 
ensure those who are approved persons exercising management functions act with the 
businesses in accordance with regulatory requirements and standards and to behave 
towards the FSA in an open and cooperative manner. The FSA considered that a 
penalty should be imposed to demonstrate to you and others the seriousness with 
which the FSA regards such behaviour.  
The nature, seriousness and impact of the breach in question (DEPP 6.5.2(2)) 
5.6. 
Your failures exposed customers to a risk of receiving unsuitable recommendations in 
relation to retail investment products. Due to your failure to take reasonable steps to 
ensure that the LLP retained appropriate records to demonstrate whether its advisers 
assessed and, if so, the basis on which its advisers assessed the suitability of the 
products they recommended, the FSA was unable to satisfy itself that customers were 
recommended suitable investment products.  
The extent to which the breach was deliberate or reckless (DEPP 6.5.2(3)) 
5.7. 
The FSA concluded that your contraventions were not deliberate.  However, the FSA 
considered that the nature of your actions (and inaction) as set out in section 4 of this 
Notice amounted to serious misconduct.   
Whether the person on whom the penalty is to be imposed is an individual (DEPP 
6.5.2(4)) 
5.8. 
When determining the appropriate level of financial penalty, the FSA will take into 
account that individuals will not always have the same resources as a body corporate, 
that enforcement action may have a greater impact on an individual, and further, that 
it may be possible to achieve effective deterrence by imposing a smaller penalty on an 
individual than a body corporate. The FSA will also consider whether the status, 
position and/or responsibilities of the individuals are such as to make a breach 
committed by the individual more serious and whether the penalty should therefore be 
set at a higher level.   
5.9. 
The FSA recognised that the financial penalty imposed on you was likely to have a 
significant impact on you as an individual but it was considered to be proportionate in 
relation to the seriousness of the misconduct and given your position as an approved 
person performing significant influence functions at the LLP. 
The size, financial resources and other circumstances of the person on whom the 
penalty is to be imposed (DEPP 6.5.2(5)) 
5.10. The FSA considered that the financial penalty described above was appropriate, 
having taken account of all relevant factors.  
The amount of benefit gained or loss avoided (DEPP 6.5.2.G(6)) 
5.11. The FSA did not establish that you obtained any financial benefit or avoided any loss 
as a result of the breaches. 
Conduct following the breach (DEPP 6.5.2G(8)) 
5.12. The FSA noted your co-operation with the FSA’s investigation in that you attended an 
interview and answered the investigators’ questions, but it also took into account your 
failure to reply to all document requests.  
Disciplinary record and compliance history (DEPP 6.5.2G(9)) 
5.13. The FSA took into account the fact that you have not been the subject of previous 
disciplinary action by the FSA. 
Other action taken by the FSA (DEPP 6.5.2G(10)) 
5.14. The FSA has taken action against other approved persons for similar misconduct.  
5.15. The FSA therefore decided to impose a financial penalty of £25,000 on you, reduced 
to £17,500 to take account of the settlement discount described above.  
Withdrawal of approval and prohibition 
5.16. The FSA had regard to the guidance in Chapter 9 of the Enforcement Guide (EG) in 
deciding that a Prohibition Order, Time Limited Prohibition Order and a withdrawal 
of approval were appropriate in this case.  The relevant provisions of EG are set out in 
Annex A of this notice. 
5.17. Given the nature and seriousness of the failures outlined above, the FSA concluded 
that you were not competent and capable to perform significant influence functions at 
an authorised firm.  As such you were not fit and proper to perform such functions. It 
was therefore decided that your individual approval should be withdrawn and you 
should be prohibited from performing such functions in the interest of protecting 
consumers. 
6. 
CONCLUSIONS 
6.1. 
On the basis of the facts and matters described above, the FSA concluded that your 
conduct fell short of the minimum regulatory standards required of an approved 
person and that you breached Statements of Principle 2 and 7. 
6.2. 
The FSA, having regard to all the circumstances, therefore decided that it was 
appropriate and proportionate to impose a financial penalty of £17,500 on you, to 
withdraw your approval and to make the Prohibition Order and Time Limited 
Prohibition Order against you.  The effective date of the sanctions in this Final Notice 
is 25 November 2010. 
7. 
DECISION MAKER 
7.1. 
The decision which gave rise to the obligation to give this Final Notice was made on 
behalf of the FSA by Settlement Decision Makers for the purposes of the FSA’s 
Decision Procedure and Penalties Manual.  
8. 
IMPORTANT 
8.1. 
This Final Notice is given to you in accordance with section 390 of the Act. 
Manner and time of payment 
8.2. 
The financial penalty must be paid in full by you to the FSA by no later than 9 
December 2010, 14 days after the date of this Final Notice. 
If the financial penalty is not paid 
8.3. 
If all or any of the financial penalty is outstanding on the due date, the FSA may 
recover the outstanding amount as a debt owed by you and due to the FSA. 
8.4. 
Sections 391(4), 392(6) and 391(7) of the Act apply to the publication of information 
about the matter to which this Final Notice relates.  Under those provisions, the FSA 
must publish such information about the matter to which this Notice relates as the 
FSA considers appropriate.  The information may be published in such manner as the 
FSA considers appropriate.  However, the FSA may not publish information if such 
publication would, in the opinion of the FSA, be unfair to you or prejudicial to the 
interests of consumers. 
8.5. 
The FSA intends to publish such information about the matter to which this Final 
Notice relates as it considers appropriate. 
FSA contacts 
8.6. 
For more information concerning this matter generally, you should contact Chris 
Walmsley at the FSA (direct line: 020 7066 5894/ fax: 020 7066 5895). 
Tom Spender 
Head of Department 
Enforcement and Financial Crime Division 
ANNEX A 
RELEVANT STAUTORY PROVISIONS, REGULATORY REQUIREMENTS AND 
FSA GUIDANCE 
1. 
Statutory provisions 
1.1. 
The FSA’s statutory objectives, set out in Section 2(2) of the Act, include the 
protection of consumers. 
1.2. 
The FSA has the power, by virtue of section 66 of the Act, to impose a financial 
penalty on you of such amount as it considers appropriate where it appears to the FSA 
that you are guilty of misconduct and it is satisfied that it is appropriate in all the 
circumstances to take action against you.   
1.3. 
You are guilty of misconduct if, while an approved person, you fail to comply with a 
statement of principle issued under section 64 or have been knowingly concerned in a 
contravention by the relevant authorised person of a requirement imposed on that 
authorised person by or under the Act. 
1.4. 
Pursuant to section 63 of the Act, the FSA has the power to withdraw the approval 
given to you under section 59 of the Act – to perform the significant controlled 
functions of CF4 Partner, CF10 Compliance Oversight and CF11 Money Laundering 
Reporting – if it considers that you are not a fit and proper person to perform them.  
2. 
APER Statements of Principle for Approved Persons 
2.1. 
APER is issued pursuant to section 64 of the Act.  It sets out Statements of Principle 
with which approved persons are required to comply when performing a controlled 
function for which approval has been sought and granted.  They are general 
statements of the fundamental obligations of approved persons under the regulatory 
system.  APER also contains descriptions of conduct which, in the opinion of the 
FSA, constitutes a failure to comply with a particular Statement of Principle and 
describes factors which the FSA will take into account in determining whether an 
approved person’s conduct complies with it. 
2.2. 
APER 3.1.3G states, as guidance, that, when establishing compliance with, or breach 
of, a Statement of Principle, account will be taken of the context in which a course of 
conduct was undertaken, the precise circumstances of the individual case, the 
characteristics of the particular controlled function and the behaviour expected in that 
function.   
2.3. 
APER 3.1.4G states, as guidance, that an approved person will only be in breach of a 
Statement of Principle if they are personally culpable, that is in a situation where their 
conduct was deliberate or where their standard of conduct was below that which 
would be reasonable in all the circumstances. 
2.4. 
In this case, the FSA considers the most relevant Statements of Principle to be 
Statement of Principle 2 and Statement of Principle 7.   
2.5. 
Statement of Principle 2 requires that an approved person must act with due skill, care 
and diligence in carrying out his controlled function. 
2.6. 
Statement of Principle 7 requires that an approved person performing a significant 
influence function must take reasonable steps to ensure that the business of the firm 
for which he is responsible in his controlled function complies with the relevant 
requirements and standards of the regulatory system. 
2.7. 
APER 4.2.2E to 4.2.13E provide examples of the types of behaviour that, in the 
opinion of the FSA, do not comply with Statement of Principle 2.  These include: 
(1) 
failing to inform a customer of material information in circumstance where the 
approved person ought to have been aware of such information and of the fact 
that he should provide it, including failing to explain the risks of an 
investment to a customer (APER 4.2.3E and 4.2.4E); 
(2) 
recommending an investment to a customer where the approved person does 
not have reasonable grounds to believe that it is suitable for that customer 
(APER 4.2.5E); and 
(3) 
recommending transactions without a reasonable understanding of the risk 
exposure of the transaction to a customer including where that 
recommendation is made without a reasonable understanding of the liability 
(either potential or actual) of the transaction (APER 4.2.6E and 4.2.7E)). 
2.8. 
APER 4.7.2E to 4.7.10E provide examples of the types of behaviour that, in the 
opinion of the FSA, do not comply with Statement of Principle 7. These include: 
(1) 
failing to take reasonable steps to implement (either personally or through a 
compliance department or other departments) adequate and appropriate 
systems of control to comply with the relevant standards of the regulatory 
system in respect of the relevant firm’s regulated activities (APER 4.7.3E); 
(2) 
failing to take reasonable steps to monitor (either personally or through a 
compliance department or other departments) compliance with the relevant 
requirements and standards of the regulatory system in respect of the relevant 
firm’s regulated activities (APER 4.7.4E); and 
(3) 
in the case of an approved person performing a significant influence function 
responsible for compliance, failing to take reasonable steps to ensure that 
appropriate compliance systems and procedures are in place (APER 4.7.10E). 
3. 
FSA’s policy on exercising its power to impose a financial penalty 
3.1. 
The FSA's statement of policy with respect to the imposition and amount of penalties 
under the Act, as required by sections 69(1), 93(1), 124(1) and 210(1) of the Act, and 
guidance on those matters is provided in Chapter 6 of the FSA’s Decision Procedure 
and Penalties Manual (“DEPP”), entitled “Penalties”, which is part of the FSA’s 
Handbook.  In summary, chapter 6 of DEPP states that the FSA will consider the full 
circumstances of each case when determining whether or not to take action for a 
financial penalty, and sets out a non-exhaustive list of factors that may be relevant for 
this purpose.   
3.2. 
The principal purpose of imposing a financial penalty is to promote high standards of 
regulatory conduct by deterring persons who have committed breaches from 
committing further breaches, helping to deter other persons from committing similar 
breaches and demonstrating generally the benefits of compliant behaviour. 
3.3. 
The FSA will consider the full circumstances of each case when determining whether 
or not to take action for a financial penalty. DEPP6.2.1G sets out guidance on a non-
exhaustive list of factors that may be of relevance in determining whether to take 
action for a financial penalty, which include the following. 
(1) 
DEPP 6.2.1G(1): The nature, seriousness and impact of the suspected breach. 
(2) 
DEPP 6.2.1G(2): The conduct of the person after the breach. 
(3) 
DEPP 6.2.1G(3): The previous disciplinary record and compliance history of 
the person. 
(4) 
DEPP 6.2.1G(4): FSA guidance and other published materials. 
(5) 
DEPP 6.2.1G(5): Action taken by the FSA in previous similar cases. 
4. 
Determining the level of the financial penalty 
4.1. 
The FSA will consider all the relevant circumstances of a case when it determines the 
level of financial penalty.  DEPP 6.5.2G sets out guidance on a non exhaustive list of 
factors that may be of relevance when determining the amount of a financial penalty. 
4.2. 
Factors that may be relevant to determining the appropriate level of financial penalty 
include: 
(1) 
whether the breach revealed serious or systematic weaknesses in the person's 
procedures or of the management systems or internal controls relating to all or 
part of a person's business (DEPP 6.5.2G(2)(b)); and 
(2) 
the general compliance history of the person, including whether the FSA has 
previously brought to the person's attention, issues similar or related to the 
conduct that constitutes the breach in respect of which the penalty is imposed 
(DEPP 6.5.2(9)(d)).   
5. 
Fit and Proper Test for Approved Persons 
5.1. 
The part of the FSA Handbook entitled “FIT” sets out the Fit and Proper Test for 
Approved Persons.  The purpose of FIT is to outline the main criteria for assessing the 
fitness and propriety of a candidate for a controlled function. FIT is also relevant in 
assessing the continuing fitness and propriety of an approved person.     
5.2. 
FIT 1.3.1G provides that the FSA will have regard to a number of factors when 
assessing a person’s fitness and propriety. One of the considerations will be the 
person’s competence and capability. 
5.3. 
As set out in FIT 2.2, in determining a person’s competence and capability, the FSA 
will have regard to matters including but not limited to:  
(1) 
whether the person satisfies the relevant FSA training and competence 
requirements in relation to the controlled function the person performs or is 
intended to perform; and 
(2) 
whether the person has demonstrated by experience and training that the 
person is able, or will be able if approved, to perform the controlled function.  
6. 
FSA’s policy for exercising its power to make a prohibition order and withdraw 
a person’s approval 
6.1. 
The FSA’s approach to exercising its powers to make prohibition orders and withdraw 
approvals is set out at Chapter 9 of the Enforcement Guide (“EG”).     
6.2. 
EG 9.1 states that the FSA’s power to make prohibition orders under section 56 of the 
Act helps it work towards achieving its regulatory objectives.  The FSA may exercise 
this power where it considers that, to achieve any of those objectives, it is appropriate 
either to prevent an individual from performing any functions in relation to regulated 
activities or to restrict the functions which he may perform. 
6.3. 
EG 9.4 sets out the general scope of the FSA’s powers in this respect, which include 
the power to make a range of prohibition orders depending on the circumstances of 
each case and the range of regulated activities to which the individual’s lack of fitness 
and propriety is relevant.  EG 9.5 provides that the scope of a prohibition order will 
vary according to the range of functions which the individual concerned performs in 
relation to regulated activities, the reasons why he is not fit and proper and the 
severity of risk posed by him to consumers or the market generally.  
6.4. 
In circumstances where the FSA has concerns about the fitness and propriety of an 
approved person, EG 9.8 to 9.14 provides guidance. In particular, EG 9.8 states that 
the FSA may consider whether it should prohibit that person from performing 
functions in relation to regulated activities, withdraw that person’s approval or both. 
In deciding whether to withdraw approval and/or make a prohibition order, the FSA 
will consider whether its regulatory objectives can be achieved adequately by 
imposing disciplinary sanctions. 
6.5. 
EG 9.9 states that the FSA will consider all the relevant circumstances when deciding 
whether to make a prohibition order against an approved person and/or to withdraw 
that person’s approval.  Such circumstances may include, but are not limited to, the 
following factors: 
(1) 
whether the individual is fit and proper to perform functions in relation to 
regulated activities, including in relation to the criteria for assessing the fitness 
and propriety of an approved person in terms of competence and capability as 
set out in FIT 2.2;  
(2) 
the relevance and materiality of any matters indicating unfitness; 
(3) 
the length of time since the occurrence of any matters indicating unfitness;  
(4) 
the particular controlled function the approved person is (or was) performing, 
the nature and activities of the firm concerned and the markets in which he 
operates;  
(5) 
the severity of the risk which the individual poses to consumers and to 
confidence in the financial system; and 
(6) 
the previous disciplinary record and general compliance history of the 
individual. 
6.6. 
EG 9.12 provides a number of examples of types of behaviour which have previously 
resulted in the FSA deciding to issue a prohibition order or withdraw the approval of 
an approved person. The examples include serious lack of competence.   
7. 
Conflict of interest 
7.1. 
Statement of Principle 8 requires that a firm must manage conflicts of interest fairly, 
both between itself and its customer and between a customer and another client. 
8. 
Complaints handling rules 
8.1. 
DISP 1.3.1 R in the part of the Handbook entitled Dispute Resolution: Complaints 
(“DISP”) requires that effective and transparent procedures for the reasonable and 
prompt handling of complaints must be established, implemented and maintained by 
the respondent. 
8.2. 
DISP 1.4.1 R requires that once a complaint has been received by a respondent, it 
must  
(1) 
investigate the complaint competently, diligently and impartially, 
(2) 
assess fairly, consistently and promptly the subject matter of the complaint, 
whether the complaint should be upheld, what remedial action or redress (or 
both) may be appropriate and, if appropriate, whether it has reasonable 
grounds to be satisfied that another respondent may be solely or jointly 
responsible for the matter alleged in the complaint. 
8.3. DISP 1.6.1 R requires that on receipt of a complaint:  
(1) 
a respondent must send the complainant a prompt written acknowledgement 
providing early reassurance that it has received the complaint and is dealing 
with it, and  
(2) 
ensure the complainant is kept informed thereafter of the progress of the 
measures being taken for the complaint’s resolution. 
8.4. DISP 1.6.2 R requires that the respondent must, by the end of eight weeks after its 
receipt of the complaint, send the complainant: 
(1) 
a final response; or 
(2) 
a written response which explains why it is not in a position to make a final 
response and indicate when it expects to be able to provide one, inform the 
complainant that he may now refer the complaint to the FOS, and enclose a 
copy of the FOS standard explanatory leaflet. 
ANNEX B 
9. 
Promotion of collective investment schemes 
9.1. 
Section 238(1) of the Act provides that an authorised person must not communicate 
an invitation or inducement to participate in a collective investment scheme (“CIS”), 
and therefore also an UCIS.  Section 21 of the Act imposes an equivalent restriction in 
relation to unauthorised persons. 
9.2. 
Section 238 goes on expressly to carve out circumstances where this prohibition will 
not apply. These include: 
(1) 
Where the CIS in question is an authorised unit trust/open ended investment 
company or a recognised scheme (s238 (4)). 
(2) 
The Treasury may by order specify circumstances (s238 (6) - i.e. there is a 
statutory exemption in an order made by the Treasury - the FSMA 2000 
(Promotion of Collective Investment Schemes (Exemptions) Order 2001 (“PCIS 
Order”);  
(3) 
The financial promotion is permitted under FSA rules exempting the promotion 
of UCIS under certain circumstances (s238 (5) (COBS 4.12) 
9.3. 
The PCIS Order provides for authorised firms to promote UCIS to individuals if they 
fall within a particular category of exemption set out in the order. 
9.4. 
These exemptions pertain to a certain category of individuals, for example certified 
high net worth individuals, certified sophisticated investors or self-certified 
sophisticated investors (articles 21, 23 and 23A of the PCIS Order). 
10. 
The PCIS Order exemptions - Certified high net worth individuals  
10.1. Article 21(2) defines a certified high net worth individual as being an individual who 
has signed a statement complying with Part I of the Schedule to the PCIS Order in the 
past 12 months. Essentially this requires that at least one of the following sets of 
circumstances apply: 
(1) 
The person had, during the previous financial year immediately preceding the 
date of the statement, an annual income of £100,000 or more; and/or 
(2) 
The person held, throughout the previous financial year immediately preceding 
the date of the statement, net assets to the value of £250,000 or more, not 
including that person's primary residence or any loan secured on that residence; 
that person's rights under a qualifying contract of insurance within the meaning 
of the Financial Services and Markets Act 2000 (Regulated Activities) Order 
2001 (a); or any benefits (in the form of pensions or otherwise) which are 
payable on the termination of that person's service or on that person's death or 
retirement and to which that person is (or that person's dependants are), or may 
be, entitled. 
10.2. The statement also requires that the person signs a statement to indicate he accepts 
that he can lose his property and other assets from making investment decisions based 
on financial promotions and is aware it is open to him to seek specialist advice. 
10.3. If the person making the communication believes on reasonable grounds that he is 
making it to a certified high net worth individual, then the section 238 restriction will 
not apply as long as the communication: 
(1) 
 is a non-real time communication or a solicited real time communication;  
(2) 
relates only to units in a UCIS which invests wholly or predominantly in the 
shares in or debentures of one or more unlisted companies; 
(3) 
does not invite or induce the recipient to enter into an agreement under the 
terms of which he can incur a liability or obligation to pay or contribute more 
than he commits by way of investment; 
(4) 
a specified warning in the following terms is given both orally (in respect of a 
real-time communication) and in writing in the manner prescribed in Article 
21: 
“Reliance on this promotion for the purpose of buying the units to which the 
promotion relates may expose an individual to a significant risk of losing all of 
the property or other assets invested.”; and 
(5) 
is accompanied by an indication that the promotion is exempt from section 238 
on the grounds that it is communicated to a certified high net worth individual, 
together with details of the requirements for certified high net worth investors 
and a reminder that the individual should consult a specialist if in any doubt 
about participating in a UCIS. 
10.4. There are similar provisions for high net worth companies and associations at Article 
22. 
11. 
The PCIS Order exemptions - Sophisticated investors 
11.1. There are two sorts of sophisticated investors referred to in the PCIS Order – certified 
and self-certified. 
Certified sophisticated investors 
11.2. A certified sophisticated investor is defined in Article 23(1) as someone: 
(1) 
Who has a current certificate (signed and dated in the past three years) in 
writing or other legible form signed by an authorised person to the effect that 
he is sufficiently knowledgeable to understand the risks associated with 
participating in a UCIS; and 
(2) 
Who has signed, within the previous 12 months, a statement in the following 
terms 
“I make this statement so I can receive promotions which are exempt from the 
restriction on promotion of unregulated schemes in the Financial Services and 
Markets Act 2000. The exemption relates to certified sophisticated investors and I 
declare that I qualify as such. I accept that the schemes to which the promotions will 
relate are not authorised or recognised for the purposes of that Act. I am aware that it 
is open to me to seek advice from an authorised person who specialises in advising on 
this kind of investment.” 
11.3. The communication must be accompanied by an indication that section 238 does not 
apply, of the requirements to be a certified sophisticated investor, a prescribed risk 
warning and a reminder to seek independent advice. 
11.4. Provided all this is met, and the communication is not to participate in a UCIS carried 
on by the person who certified the investor as sophisticated, then the section 238 
restriction will not apply. 
Self-certified sophisticated investors 
11.5. Article 23A defines a self-certified sophisticated investor as an individual who has 
signed a statement complying with Part II of the Schedule to the PCIS Order in the 
past 12 months. Essentially this requires that at least one of the following sets of 
circumstances applies to the investor: 
(1) 
He is a member of a network or syndicate of “business angels” and has been so 
for at least the last six months; 
(2) 
He has made more than one investment in an unlisted company in the past two 
years; 
(3) 
He is working, or has worked in the past two years, in a professional capacity 
in the private equity sector, or in the provision of finance for small and 
medium enterprises; 
(4) 
He is currently, or has been in the two years before signing the statement, a 
director of a company with an annual turnover of at least £1 million. 
11.6. As with high net worth individuals, the statement also requires the investor to sign a 
statement that he accepts he can lose his property and assets from making investment 
decisions based on financial promotions and that he is aware that it is open to him to 
seek specialist advice. 
11.7. If the person making the communication believes on reasonable grounds that he is 
making it to a self-certified sophisticated investor, then the section 238 restriction will 
not apply as long as the communication: 
(1) 
relates only to units in a UCIS which invests wholly or predominantly in the 
shares in or debentures of one or more unlisted companies; 
(2) 
does not invite or induce the recipient to enter into an agreement under the 
terms of which he can incur a liability or obligation to pay or contribute more 
than he commits by way of investment; 
(3) 
a specified warning in the following terms is given both orally (in respect of 
real time communications) and in writing in the manner prescribed in Article 
23A: 
“Reliance on this promotion for the purpose of buying the units to which the 
promotion relates may expose an individual to a significant risk of losing all of 
the property or other assets invested.”; and 
(4) 
is accompanied by an indication that the promotion is exempt from section 238 
on the ground that it is made to a self-certified sophisticated investor, together 
with details of the requirements for self-certified sophisticated investors and a 
reminder that the individual should consult a specialist if in any doubt about 
participating in a UCIS. 
12. 
The COBS exemptions 
12.1. A firm may communicate an invitation or inducement to participate in a UCIS without 
breaching the section 238 restriction if the promotion falls within an exemption listed 
in the table at 4.12.1R(4) of the Conduct of Business Sourcebook (COBS). 
12.2. The inducement or invitation must be made only to recipients whom the firm has 
taken reasonable steps to establish are persons in that category or be directed at 
recipients in such a way as to reduce, as far as possible, the risk of participation in the 
CIS by persons not in that category.  There is no provision for these steps to be taken 
retrospectively. 
12.3. Category 1 covers people who are already participants in a UCIS or have been so in 
the last 30 months. An authorised person can promote to these persons the UCIS in 
which they are already participants (and any successor scheme) or one whose 
underlying property and risk profile are both “substantially similar” to those of the 
UCIS in which they participate. 
12.4. Category 2 deals with those persons for whom the firm has taken reasonable steps to 
ensure that investment in the UCIS is suitable and who is a client of the firm or a 
company in its group. 
12.5. Category 7 provides that if a client is categorised as a professional client or eligible 
counterparty then an authorised person can promote to that client any UCIS in relation 
to which the client is so categorised. 
12.6. Category 8 allows financial promotion of UCIS to a person: 
(1) 
In relation to whom the firm has undertaken an adequate assessment of his 
expertise, experience and knowledge and that assessment gives reasonable 
assurance, in light of the nature of the transactions or services envisaged, that 
the person is capable of making his own investment decisions and 
understanding the risks involved; 
(2) 
To whom the firm has given a clear written warning that this will enable the 
firm to promote UCIS to the client; and 
(3) 
Who has stated in writing, in a document separate from the contract, that he is 
aware of the fact the firm can promote certain UCIS to him. 
13. 
Suitability of advice 
13.1. The fact that a customer is eligible to receive a communication promoting a UCIS 
under one or more exemptions does not mean that UCIS will be automatically suitable 
to that customer. 
13.2. Principle 9 of the FSA’s Principles for Businesses states a firm must take reasonable 
care to ensure the suitability of its advice and discretionary decisions for any customer 
who is entitled to rely upon its judgment. 
13.3.  In considering the suitability of a particular scheme for a specific client, a firm is 
required by COBS 9 to obtain the necessary information to understand the essential 
facts about the client (COBS 9.2.2R). 
13.4.  COBS 9.2.6R provides that if a firm does not obtain the necessary information to 
assess suitability, it must not make a personal recommendation to the client. 
